The Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center and New York Presbyterian Hospital is a growing, highly funded research institution that focuses on researching all aspects of cancers. Since it's establishment in 1972, the HICCC has continuously performed world-renowned research and clinical trials.
With the recent award of a five year, $18 million grant from the National Cancer Institute, the Herbert Irving Comprehensive Cancer Center (HICCC) at the Columbia University Medical Center renewed it's status as one of only two NCI-designated Comprehensive Cancer Centers in New York City, one of only three in New York State, and one of only 41 in the United States.
The Herbert Irving Comprehensive Cancer Center received $18 million to support cancer research (Image courtesy of Columbia Newsroom)
Current areas of study at the HICCC include:
- Cancer Regulatory Networks Program that studies and maps genes that drive aggressive forms of cancer.
- Breast Cancer Program which studies different risks associated with different treatments for Breast Cancer.
- Neuro-Oncology Research for studying the systems biology, genetics, cell biology and therapy of brain tumors.
- Leukemia Research focused on finding new drug targets.
- Cancer Epidemiology that studies how environmental, lifestyle and genetic factors lead to increased incidences of cancer.
$1.5 Billion Life Science Research in the Big Apple
Mount Sinai Receives $1.5M in Lab Funding to Study Toxins and Fetal Development
Lee Goldman, MD, MPH, a Professor of Medicine at the Columbia University College of Physicians and Surgeons explained that “both clinical and research programs at the Herbert Irving Comprehensive Cancer Center have grown significantly in the past several years under the leadership of Dr. Stephen Emerson, and this grant recognizes our potential to change the way cancer is diagnosed, treated, and prevented. This latest renewal will ensure continuity of our current research, patient care, and educational programs as we continue to add leading cancer researchers and clinicians to our extremely talented and dedicated team.”
- HICCC researchers currently have more than $120 million in active NIH and NCI research grants.
- The HICCC has over 250 members that come from 6 Columbia University schools.
- There are 12 core facilities, and 8 research programs at the HICCC
- Clinicians diagnose and treat more than 3,500 new cases of cancer each year.
- In the most recent NCI funding cycle, HICCC researchers published more than 3,000 research publications.
- There are 200 active clinical trials for HICCC patients.
Columbia University in New York (Image courtesy of Wikimedia Commons)
Columbia University is a nearly $1 billion research market with ongoing research products spanning all fields in the life sciences. Biotechnology Calendar, Inc. has been producing an annual BioResearch Product Faire™ Event at the Armory Track and Field Center adjacent to Columbia University that has been highly attended by both vendors and researchers. Because of this high attendance, the event will begin to be held twice a year starting in 2015. Exhibitors can now market their lab supplies to active researchers at Columbia in both the Spring and Fall.
To learn more about exhibiting at Columbia in Spring, on March 24, 2015, please visit the link below, where you can also getting funding stats about current grants and awards at Columbia University. To find information about the more than 50 events happening in 2015, visit the 2015 event schedule here.
Researches at Columbia University are invited to visit the link below to pre-register for the upcoming Spring event on March 24, 2015.